Innovent Biologics, Inc. (FRA:6IB)

Innovent Biologics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	15,162	7,456	8,030	6,168	7,955	12,136
Market Cap Growth	124.00%	-7.15%	30.17%	-22.46%	-34.45%	216.45%
Enterprise Value	14,434	6,750	7,395	5,388	6,693	11,531
Last Close Price	8.65	4.36	4.50	3.84	5.10	8.05
PS Ratio	11.17	5.98	10.14	9.98	13.46	25.21
PB Ratio	8.84	4.30	5.02	4.24	5.56	11.04
P/TBV Ratio	9.79	4.40	5.04	4.25	5.57	11.04
P/FCF Ratio	88.11	175.32	-	-	-	-
P/OCF Ratio	70.22	43.78	425.78	-	-	-
EV/Sales Ratio	10.70	5.41	9.34	8.72	11.33	23.96
EV/EBITDA Ratio	96.68	2126.28	-	-	-	-
EV/FCF Ratio	83.88	158.73	-	-	-	-
Debt / Equity Ratio	0.23	0.22	0.29	0.30	0.24	0.14
Debt / EBITDA Ratio	2.54	50.93	-	-	-	-
Debt / FCF Ratio	2.33	8.81	-	-	-	-
Asset Turnover	0.52	0.45	0.33	0.27	0.30	0.40
Inventory Turnover	2.94	2.69	1.51	1.00	1.19	1.45
Quick Ratio	2.25	2.08	2.68	2.78	3.27	5.85
Current Ratio	2.61	2.35	3.00	3.29	3.79	6.37
Return on Equity (ROE)	8.43%	-0.74%	-8.84%	-20.70%	-28.56%	-14.75%
Return on Assets (ROA)	2.65%	-0.82%	-5.12%	-11.54%	-12.04%	-3.65%
Return on Capital Employed (ROCE)	5.00%	-1.60%	-9.70%	-22.20%	-20.50%	-5.40%
Earnings Yield	0.89%	-0.17%	-1.63%	-4.79%	-4.75%	-1.03%
FCF Yield	1.13%	0.57%	-1.54%	-6.19%	-5.38%	-0.82%
Buyback Yield / Dilution	-3.74%	-4.35%	-4.67%	-2.37%	-7.27%	-15.23%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.